Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	186.73	125.74	123.67	117.37	33.02
Short-Term Investments	154.89	111.61	203.24	188.45	100.01
Cash & Cash Equivalents	341.62	237.36	326.9	305.82	133.03
Cash Growth	43.93%	-27.39%	6.89%	129.89%	3.23%
Receivables	10	0.01	1.57	2.43	6.76
Other Current Assets	3.96	5.71	12.27	7.36	5.53
Total Current Assets	355.58	243.08	340.74	315.61	145.31
Property, Plant & Equipment	2.15	4.63	6.73	6.41	7.72
Long-Term Investments	0	0	0	2	0
Other Long-Term Assets	0.23	0.23	0.23	0.45	1.88
Total Long-Term Assets	2.37	4.85	6.96	8.86	9.61
Total Assets	357.95	247.93	347.7	324.47	154.92
Accounts Payable	0.78	3.71	2.5	5.81	4.05
Deferred Revenue	0	0	1.6	14.48	41.53
Current Debt	1.14	2.52	2.2	1.46	1.26
Other Current Liabilities	19.36	24.96	37.72	18.5	-11.43
Total Current Liabilities	21.27	31.18	44.02	40.24	35.41
Long-Term Debt	0	1.14	3.66	4.5	15.76
Other Long-Term Liabilities	0	0	0	0.12	23.79
Total Long-Term Liabilities	0	1.14	3.66	4.62	39.55
Total Liabilities	21.27	32.32	47.67	44.86	74.95
Total Debt	1.14	3.66	5.86	5.96	17.01
Debt Growth	-68.79%	-37.59%	-1.69%	-64.97%	-
Retained Earnings	-615.71	-536.76	-409.36	-283.81	-217.66
Comprehensive Income	-0.11	-0.36	-0.3	0.03	-0.22
Shareholders' Equity	336.68	215.61	300.02	279.61	79.96
Net Cash / Debt	340.48	233.7	321.04	299.86	116.02
Net Cash / Debt Growth	45.69%	-27.21%	7.06%	158.46%	-9.97%
Net Cash Per Share	6.00	4.77	6.93	8.72	4.48
Working Capital	334.3	211.9	296.72	275.37	109.91
Book Value Per Share	5.93	4.40	6.48	8.13	3.09

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).